LAG3 and neoplasm: Since both Lag-3 and PD-1 are co-expressed on tumor-infiltrated T cells (12), the cocktail of aLag-3 and aPD-1 functioned to reduce tumor size more effectively than each treatment alone in preclinical model systems (13).